New measures aim to reduce barriers to methadone and diacetylmorphine for the treatment of opioid use disorder and emergency funding for treatment to tackle the opioid crisis
OTTAWA, March 26, 2018 /CNW/ - The opioid crisis continues to have a devastating impact on families and communities across the country. In 2017 alone, projections suggest over 4,000 people will have lost their lives
Today, the Honourable Ginette Petitpas Taylor, Minister of Health, announced a number of important initiatives to help address the opioid crisis.
First, the Minister announced that the Government of Canada is removing barriers to accessing diacetylmorphine (prescription heroin) and methadone for the treatment of opioid use disorder. These regulatory amendments will help Canadians have greater access to a comprehensive array of treatment options. For example, for methadone, health care practitioners will be able to prescribe and administer methadone treatment without needing to apply for an exemption from federal law. For diacetylmorphine, the amendments will provide flexibility by allowing patients to receive the product outside a hospital setting, such as substance use disorder clinics, thereby allowing patients to balance their daily responsibilities with their treatment. The regulatory amendments were published in the Canada Gazette, Part II on March 21, 2018.
Second, Minister Petitpas Taylor announced $18 million in federal investments for six innovative projects under the Substance Use and Addictions Program, and ten research projects related to opioids funded through the Canadian Institutes of Health Research (CIHR). These projects will explore drug checking in supervised consumption sites, opioid use in pain management, the development of guidance material for prevention and treatment of opioid use disorder, and to look at how opioid-related treatment can better address the needs of women.
Third, the Health Minister announced details of the $231.4 million investments proposed in Budget 2018 to improve access to treatment, address stigma and gather more data to help address the opioid crisis. These investments include:
Minister Petitpas Taylor concluded the event by thanking the Canadian Research Initiative in Substance Misuse (CRISM) for its recently released report and recommendations on removing regulatory barriers to methadone treatment and its expertise on developing a national clinical practice guideline on the management of opioid use disorders. These recommendations helped shape the regulatory amendments announced today on methadone.
"We should not judge people with substance use problems but instead make sure they are getting the help they need, when they want it. The changes we announce today will allow health care practitioners to prescribe and administer methadone treatment without needing to apply for an exemption. The new funding proposed in Budget 2018 will also help us improve treatment, reduce stigma and gather more data to reverse the heartbreaking trend of opioid-related deaths in Canada."
The Honourable Ginette Petitpas TaylorMinister of Health
"There's no doubt that the illegal production and trafficking of opioids, including fentanyl, have contributed to a public health crisis in Canada. We recognize that this is a complex social, health and public safety issue and we are committed to an approach to this crisis that is comprehensive, collaborative, compassionate and evidence-based."
The Honourable Ralph GoodaleMinister of Public Safety and Emergency Preparedness
"It is important for us to signal to those who use drugs and the people around them that treatment is an individualized journey. Better access to treatment options and additional funding announced today will enhance our collective ability to respond to address the opioid crisis in a comprehensive and collaborative manner."
Dr. Theresa TamChief Public Health Officer of Canada
SOURCE Health Canada
Subscribe to our Free Newsletters!
Menstruation or period is the discharge of blood and mucus called menses from the uterus via the ...
Chronic dieting is associated with eating disorders that mainly include unhealthy eating practices ...
Some medications affect the normal function of thyroid gland leading to thyroid function disorders ...View All